EP3641772
TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.6.2018:
2.8.2023:
18819790.9
:
20.6.2038
:
TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION
21.6.2018
2.8.2023
:
Celgene Corporation:
86 Morris Avenue, Summit, NJ 07901, US
:
FILVAROFF, Ellen:
San Francisco CA 94121, US
:
HEGE, Kristen, M.:
Burlingame CA 94010, US
:
LI, Shaoyi:
Warren NJ 07059, US
:
201762523688 P:
22.6.2017:
US
:
US2018038697:
21.6.2018
:
A61K 31/4985, A61P 31/12, A61P 35/00, A61K 31/44, G01N 33/50